newsfilter
← Latest News
Andreessen Horowitz·

The State of Longevity

Summary

  • The longevity movement has shifted from a fringe biohacker approach to mainstream adoption, accelerated by the COVID-19 pandemic & the accessibility of AI tools like ChatGPT.
  • A new "healthcare home" race is underway where companies aim to become a single app managing medical records, labs, wearables, & care delivery using AI.
  • Consumer spending on non-toxic products is surging, with 63% aware of microplastics, 70% filtering water, & 62% willing to pay more for "non-toxic" labels.
  • Interest in unregulated peptides is growing for recovery & appearance, though the market remains unproven compared to the $44 billion in sales from FDA-approved GLP-1 drugs like tirzepatide.
  • Cholesterol management is evolving into a proactive conversation, driven by new drugs like the pill-based PCSK9 inhibitor Lipfendra & emerging treatments for Lp(a).
  • Wearables are entering a third generation focused on specific biomarkers like hormones & blood flow, supported by FDA deregulation of non-invasive wellness claims.
  • Brain-computer interfaces & neurotechnology are advancing from clinical paralysis treatments to consumer applications for sleep, focus, & direct thought-to-AI communication.
  • Founders are encouraged to build companies that help consumers translate health interest into actionable, long-term behaviors across these emerging sectors.

The longevity movement is here to stay (no pun intended). Not long ago, taking care of our health largely meant following our doctor’s advice and sticking to what our insurance covered. There has always been a fringe movement of biohackers and crunchy people taking a more hands-on approach, but that mindset has only recently moved...

Keywords
Bio + Healthcare